A member of
About EurexOTC Clear
EMIR 3.0 - active account
CCP Switch
On-boarding
Compression Service
Product Scope
Interest Rate Swaps
Inflation Swaps
Settlement Prices
Service Offering for PSAs
Clearing Member
ISA Direct Member
ISA Direct Light Licence Holder
Clearing Agent
Client
Jurisdictions
Multiple Clearing Relationships
Segregation Set up
Cross-Project-Calendar
Readiness for projects
C7 Releases
C7 SCS Releases
C7 CAS Releases
EurexOTC Clear Releases
Prisma Releases
Member Section Releases
Simulation calendar
Archive
User ID Maintenance
Clearing Hours
Clearing Reports
Product Specifications
Clearing on behalf
Delivery Management
Transaction Management
Collateral Management
Collateral
Transparency Enabler Files
Segregation Models
Reports
Default Fund
Intraday Margin Calls
OTC Clear Procedures
OTC Clear Tutorials
Cross Margining Support
Supplementary Margins
Default Waterfall
Model Validation
Stress testing
Default Management Process
Client Asset Protection under EMIR
Client Asset Protection under LSOC
Credit, concentration & wrong way risk
System-based risk controls
Pioneering CCP Transparency
Haircut and adjusted exchange rates
Securities margin groups and classes
Prices Rolling Spot Future
File services
Bond Clusters
Listed derivatives
OTC derivatives
Listed securities
Cash management
Delivery management
CCP eligible instruments
Eurex Newsletter Subscription
Circulars & Newsflashes Subscription
Corporate Action Information Subscription
Circulars & Readiness Newsflashes
News
Videos
Webcasts on demand
Publications
Forms
Events
FAQs
Production Newsboard
Eurex
July marked performance divergence in key regional equity markets; U.S. stocks kept marching up while Europe was a more mixed picture at a country level. Meanwhile, Emerging Markets saw the weakest development, driven by the latest Chinese regulatory interventions. Investors remain fearful of which sectors will be targeted next. Some analysts see China as temporarily un-investable. Therefore, the reaction has been to sell now and ask questions later.
Turning the focus to Eurex data, we have strong volume growth compared to July last year for the VSTOXX® and STOXX® Europe 600 futures. This broader European benchmark continues to attract clients in search of a Pan-European answer to the S&P 500. Looking at the index options, we saw another strong month of activity in the EURO STOXX® Banks and the EURO STOXX 50® month-end options. We also observed a new participant in our Basket TRF segment. There has been a tremendous increase in interest for this listed, centrally cleared equity finance solution in the wake of the Archegos scandal.
We find ourselves in the summer holiday period, where markets traditionally slow down. But, not at Eurex! We have concrete plans for extending our MSCI derivatives suite in late Q3 and members can expect an announcement shortly. This adds to the already communicated go-live for Equity Bespoke Baskets. This innovative functionality provides a solution to transact a basket of single stock derivatives in one combined execution. It also allows for subsequent rebalancing and reshuffling. Without a doubt, market players use this quiet period to open hedges ahead of the historically volatile early Q4 period and the unfortunate uncertainty created by new COVID variants.
Zubin Ramdarshan, Head of Equity & Index Product Design, Eurex